-
Bio-Rad Laboratories Inc. Class A (BIO $250.81)
- $250.81 Cap: $6.88B
- View BIO Profile
- View Questions on BIO
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
AbbVie Inc. (ABBV $191.52)
- $191.52 Fwd P/E: 82.24X Cap: $339.94B
- View ABBV Profile
- View Questions on ABBV
-
Abbott Laboratories (ABT $132.03)
- $132.03 Fwd P/E: 17.15X Cap: $229.69B
- View ABT Profile
- View Questions on ABT
-
Danaher Corporation (DHR $197.75)
- $197.75 Fwd P/E: 39.7X Cap: $146.60B
- View DHR Profile
- View Questions on DHR
-
Eli Lilly and Company (LLY $799.34)
- $799.34 Fwd P/E: 64.52X Cap: $751.56B
- View LLY Profile
- View Questions on LLY
-
Stryker Corporation (SYK $391.46)
- $391.46 Fwd P/E: 52.63X Cap: $148.83B
- View SYK Profile
- View Questions on SYK
-
Thermo Fisher Scientific Inc (TMO $425.34)
- $425.34 Fwd P/E: 25.5X Cap: $164.15B
- View TMO Profile
- View Questions on TMO
-
UnitedHealth Group Incorporated (DE) (UNH $300.58)
- $300.58 Fwd P/E: 12.73X Cap: $275.86B
- View UNH Profile
- View Questions on UNH
-
Zoetis Inc. Class A (ZTS $155.65)
- $155.65 Fwd P/E: 27.82X Cap: $68.98B
- View ZTS Profile
- View Questions on ZTS
-
DexCom Inc. (DXCM $85.33)
- $85.33 Fwd P/E: 62.68X Cap: $32.69B
- View DXCM Profile
- View Questions on DXCM
-
STERIS plc (Ireland) (STE $225.79)
- $225.79 Fwd P/E: 36.78X Cap: $22.43B
- View STE Profile
- View Questions on STE
-
Bio-Rad Laboratories Inc. Class A (BIO $250.81)
- $250.81 Cap: $6.88B
- View BIO Profile
- View Questions on BIO
Q: Hello,
I'm looking to buy 4 or 5 US medical stocks for a long-term hold (5+ years) with an above-average level of risk tolerance.
Could you please rank the stocks I've listed, and indicate if there are better choices.
Thank you!
I'm looking to buy 4 or 5 US medical stocks for a long-term hold (5+ years) with an above-average level of risk tolerance.
Could you please rank the stocks I've listed, and indicate if there are better choices.
Thank you!
Insiders
Share Information
SEC Filings
News and Media